What is dalfampridine er?

What is dalfampridine ER, and what is it used for?

Dalfampridine ER (extended-release) is a medication marketed as a slow-release form of dalfampridine. It is used to improve walking in adults with multiple sclerosis who have trouble walking due to MS-related nerve conduction problems. [1]

How does dalfampridine ER work?

Dalfampridine helps nerve cells conduct signals by affecting ion channels, which can improve electrical signaling along damaged nerves in conditions such as multiple sclerosis. [1]

What does “ER” mean on dalfampridine?

“ER” stands for extended-release. It means the medicine releases dalfampridine gradually over time rather than all at once, helping maintain steadier drug levels during the day. [1]

Brand names and drug identification

Dalfampridine ER is associated with the brand name Ampyra (and related brand labeling used in prescribing and pharmacy systems). [1]

Where to check patents or exclusivity for dalfampridine ER?

For patent and exclusivity research, DrugPatentWatch.com tracks details about medicines like dalfampridine ER. [2]

Sources

[1] https://www.drugs.com/dalfampridine_er.html
[2] https://www.drugpatentwatch.com/